Action FRX FENNEC PHARMACEUTICALS INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Fennec Pharmaceuticals Inc. Toronto S.E.

Actions

FRX

CA31447P1009

Marché Fermé - Toronto S.E.
Autres places de cotation
 21:59:59 17/07/2024 		Varia. 5j. Varia. 1 janv.
9,1 CAD -0,55% Graphique intraday de Fennec Pharmaceuticals Inc. +12,62% -39,97%
02/07 MT Newswires Les actions du week-end à surveiller : BCE ; Bitfarms ; Fennec ; GreenPower ; Hut 8 ; Restaurant Brands ; Sigma Lithium ; Solaris MT
01/07 Fennec Pharmaceuticals Inc. annonce des changements à la direction CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
MT Newswires Weekend Stocks To Watch: BCE; Bitfarms; Fennec; GreenPower; Hut 8; Restaurant Brands; Sigma Lithium; Solaris
Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc. Announces Executive Changes
Fennec Announces Results of Annual Meeting
Fennec Pharmaceuticals : Corporate Presentation May 2024
Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue
Fennec Pharmaceuticals Brief: Company Says Has Approximately US$51 Million in Cash, Cash Equivalents, and Investment Securities
Fennec Pharmaceuticals Brief: Achieved Q1 2024 Total Net Revenues of US$25.4 Million, Including $18.0 Million in Licensing Revenue from Recently Announced Norgine Transaction
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing
Fennec Pharmaceuticals : Corporate Presentation March 2024
Wedbush on Fennec's Q4
Fennec Pharmaceuticals up 3.2% in US Premarket, Reports Narrower Q4 Loss of $0.10 Per Share
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action FENC
  4. Action FRX
  5. Actualités Fennec Pharmaceuticals Inc.
  6. Autres langues